Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study

More than two-thirds of patients with LN attain EULAR/ERA-EDTA response rates by 12 months, but 20% require therapy modifications within this time period. Patients with increased chronicity in baseline biopsy, when combined with histological activity, are at higher risk for a lack of clinical response.

Authors

Institutions

Publication Details

Journal
RMD Open
Published
2024-09-01
DOI
https://doi.org/10.1136/rmdopen-2024-004437
Citations
7
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
3.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study

George Liapis, Christina Katsiari, Myrto Nikoloudaki, Petros Paul Sfikakis et al.
7 citations
RMD Open
Systemic Lupus Erythematosus Research
3.29
article

Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study

George Liapis, Christina Katsiari, Myrto Nikoloudaki, Petros Paul Sfikakis, Antigone Pieta, Dimitrios T. Boumpas, Andreas V. Goules, Μαρία Παππά, George K Bertsias, Kyriaki Boki, Maria Kosmetatou, Paraskevi V. Voulgari, Evangelia Argyriou, Aglaia Chalkia, Antonis Fanouriakis, Harikleia Gakiopoulou, Charalampos Papagoras, Dimitrios Vassilopoulos, Prodromos I. Sidiropoulos, Theodoros Dimitroulas, Maria G. Tektonidou, Georgios Demirtzoglou, Christina Tsalapaki, Nektarios Marios Liapis, Myrto Cheila
article en
7 citations

Abstract

More than two-thirds of patients with LN attain EULAR/ERA-EDTA response rates by 12 months, but 20% require therapy modifications within this time period. Patients with increased chronicity in baseline biopsy, when combined with histological activity, are at higher risk for a lack of clinical response.

RMD OpenVol. 10(3)
University of Crete (GR), Democritus University of Thrace (GR), University of Ioannina (GR), National and Kapodistrian University of Athens (GR), Aristotle University of Thessaloniki (GR), Sismanoglio General Hospital (GR), University Hospital of Larissa (GR), Laiko General Hospital of Athens (GR), University Hospital of Alexandroupolis (GR), Hippocration General Hospital (GR), Evangelismos Hospital (GR)
Openalex Percentile: Top 8%
Systemic Lupus Erythematosus Research
3.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.